Although a potential role for SP in PD has been previously suggested, unlike in the current study, this was on the basis of decreased SP content and NK1 receptors within the BG in both clinical [16], [17], [18], [19], [20], [21] and experimental models of PD [22], [23]. This evidence concerns the gene TFF2 and Parkinson disease.